Safety and efficacy of doxazosin in benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

By Roehrborn C.G.   Siegel R.L.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 406-415

Elsevier

Access to resources Recommend Favorite

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data - oxybutynin versus propantheline versus placebo

By Larsson G.   Hallen B.   Nilvebrant L.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 990-998

Elsevier

Access to resources Recommend Favorite

Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis – system review of lanthanum carbonate

By Guo Hua   Zhang Xiaojuan   Tang Shaowen   Zhang Shali  

Renal Failure, Vol. 35, Iss. 10, 2013-11 ,pp. : 1455-1464

Informa Healthcare

Access to resources Recommend Favorite

Urologist-Acquired Renal Access for Percutaneous Renal Surgery - analysis of treatment results between initial percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy monotherapy with reference to surface area

By Lashley D.B.   Fuchs E.F.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 927-931

Elsevier

Access to resources Recommend Favorite

Results of 4-Year Analysis of Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Patients: Single-Center Experience

By Sert Mehmet   Celik Ali   Kural Kemal   Ersan Sibel   Ataca Pinar   Atila Koray   Cavdar Caner   Sifil Aykut   Bora Seymen   Gulay Hüseyin   Camsari Taner  

Renal Failure, Vol. 33, Iss. 8, 2011-09 ,pp. : 789-794

Informa Healthcare

Access to resources Recommend Favorite